Sign in
ABSCF Stock Price, Chart, Stats & News
AB Science S.A.
Save
AB Science S.A. (ABSCF) does not currently pay a dividend.
82.04M
Market cap
–
Current P/E
–
Forward P/E
ABSCF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
AB Science S. A. is a pharmaceutical company dedicated to the discovery, development, and commercialization of protein kinase inhibitors, designed for applications in both human and animal medicine. The company's flagship product is masitinib, a tyrosine kinase inhibitor currently undergoing extensive Phase III clinical trials for a diverse range of serious conditions.
Similar securities
Based on sector and market capitalization
Report issue